Effectiveness of semaglutide and tirzepatide in overweight and obese adults with type 1 diabetes
Snell-Bergeon JK, Kaur G, Renner D, et al.
Diabetes Technol Ther. Pub. online 2 Jan 2025.
Leggi
Blu
Le Breaking News di colore blu sono relative ad abstract di articoli originali di particolare rilevanza.
Predicting responsiveness to GLP-1 pathway drugs using real-world data
Zhu X, Fowler MJ, Wells QS, et al.
BMC Endocr Disord. 2024;24(1):269.
Leggi
Hybrid closed-loop insulin therapy and risk of severe hypoglycaemia and diabetic ketoacidosis in young people (aged 2-20 years) with type 1 diabetes: a population-based study
Karges B, Rosenbauer J, Stahl-Pehe A, et al.
Lancet Diabetes Endocrinol. 2024:S2213-8587(24)00284-5.
Leggi
Association between time in tight range and incident diabetic retinopathy in adults with type 2 diabetes
Wang Y, Lu J, Yu J, et al.
Diabetes Obes Metab. Pub. online 18 Dec 2024.
Leggi
Metabolic dysfunction-associated steatotic liver disease: heterogeneous pathomechanisms and effectiveness of metabolism-based treatment
Stefan N, Yki-Järvinen H, Neuschwander-Tetri BA
Lancet Diabetes Endocrinol. Pub. online 13 Dec 2024.
Leggi
Precision medicine in type 1 diabetes: comparing metabolic outcomes of Control-IQ and MiniMed 780G according to patient characteristics
Gargouri I, Charfi H, Belabed W, et al.
Diabetes Obes Metab. Pub. online 17 Dec 2024.
Leggi
Association between glycemia, glycemic variability, and pregnancy complications in early GDM
Immanuel J, Cheung NW, Mohajeri M, et al.
Diabetes Care. 2024:dc241199
Leggi
Finerenone, obesity, and heart failure with mildly reduced/preserved ejection fraction: prespecified analysis of FINEARTS-HF
Butt JH, Henderson AD, Jhund PS, et al.
J Am Coll Cardiol. 2024:S0735-1097(24)10423-8.
Leggi
Factors influencing the acceptability of automated insulin delivery systems in youths with type 1 diabetes and their parents
Franceschi R, Pertile R, Marigliano M, et al.
Diabetes Res Clin Pract. 2024:111962.
Leggi
Characteristics of autoantibody-positive individuals without high-risk HLA-DR4-DQ8 or HLA-DR3-DQ2 haplotypes
Redondo MJ, Cuthbertson D, Steck AK, et al.
Diabetologia. Pub. online 13 Dec 2024.
Leggi